Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia
Condition(s):Acute Myeloid LeukemiaLast Updated:December 25, 2009Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:December 25, 2009Unknown status
Condition(s):Common Mental DisorderLast Updated:August 12, 2020Unknown status
Condition(s):Drug-induced Liver InjuryLast Updated:July 8, 2014Completed
Condition(s):Status Epilepticus, Non-ConvulsiveLast Updated:March 10, 2015Withdrawn
Condition(s):EpilepsyLast Updated:February 11, 2022Completed
Condition(s):Brain Tumors; Epilepsy; Migraine; Mild Cognitive Impairment; Concussion; Multiple Sclerosis; Neuropathy; Parkinson’s; Restless Legs Syndrome; StrokeLast Updated:September 28, 2023Enrolling by invitation
Condition(s):Pulmonary Arterial HypertensionLast Updated:January 26, 2024Recruiting
Condition(s):Bipolar DisorderLast Updated:March 12, 2024Terminated
Condition(s):Bipolar Disorder; Attention Deficit Disorder With HyperactivityLast Updated:October 23, 2009Unknown status
Condition(s):Bipolar DisorderLast Updated:May 20, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.